FDA Adverse Event Malfunction Summary report: N

ANTERALIGN¿ SPINAL SYSTEM WITH TITAN NANOLOCK¿

MDR report key: 25199347 · Received May 18, 2026

Report

Report Number
3003120897-2026-00902
Event Type
Malfunction
Date Received
May 18, 2026
Date of Event
March 23, 2026
Report Date
May 18, 2026
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC.
Product Code
MAX
UDI-DI
00763000572181
PMA / PMN Number
K212524
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

H3: PRODUCT ANALYSIS: PART # 4680005; LOT # K23J1108 VISUAL AND OPTICAL INSPECTION CONFIRMED THE THREADED TIP OF THE TRIAL SHAFT HAS BROKEN. THE DAMAGE TO THE INSTRUMENT IS CONSISTENT WITH OVERLOAD. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

INFORMATION WAS RECEIVED FROM MULTIPLE SOURCES (MANUFACTURER REPRESENTATIVE, HEALTHCARE PROVIDER) REGARDING A DEVICE USED FOR SPINAL THERAPY. IT WAS REPORTED THAT THE DEVICES WERE STRIPPED. THERE WAS NO PATIENT INVOLVEMENT REPORTED. THERE WERE NO FURTHER COMPLICATIONS REPORTED REGARDING THE EVENT. ADDITIONAL INFORMATION WAS RECEIVED THAT THE EVENT OCCURED ON THE BACK TABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
123917 ANTERALIGN¿ SPINAL SYSTEM WITH TITAN NANOLOCK¿ INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT, MAX MEDTRONIC SOFAMOR DANEK USA, INC. 4680005 K23J1108 00763000572181

Patients

Seq Age Sex Outcome Treatment
1